Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Miravant Medical Technologies. Stock Analysis MRVT
United States N/A Nano Cap Miravant Medical Technologies engages in the research and development of drugs and medical device products for the use in proprietary technologies for photodynamic therapy. The company is headquartered in Santa Barbara, California and currently employs 47 full-time employees. The drug and light procedures involve three components, the photoselective drugs, light producing devices and light delivery devices. The firm's products have been developed in-house and with outside collaborators and have been used in various clinical and preclinical investigations. Its most advanced drug, PHOTREX, generic name rostaporfin, has completed two Phase III clinical trials for the treatment of wet age-related macular degeneration (AMD). Miravant has branded its version of PDT technology with the trademark PhotoPoint.
Read More Miravant Medical Technologies (MRVT) Chart
Financial Metrics & Statements of Miravant Medical Technologies (MRVT)
FAQ's for Miravant Medical Technologies (MRVT)
- According to Musaffa’s Shariah screening methodology, Miravant Medical Technologies (MRVT) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Miravant Medical Technologies using these criteria to determine its compliance status.
- Muslim investors may consider investing in Miravant Medical Technologies if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Miravant Medical Technologies by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Miravant Medical Technologies may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Miravant Medical Technologies on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.